The occurrence of mutations in the hypervariable region of the VH chain of the monoclonal antibodies when compared against their germline gene sequence and the observed R (Replacement) and S (Silent) mutations.

Regions beyond FR3 are not considered for the analysis as they form the junction region and the origin of the junction regions cannot be predicted accurately [57] (FR = Framework Region, CDR = Complementarity Determining Regions).